Discover 2,450 paid clinical trials in North Carolina. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
From paid studies for healthy volunteers to condition-specific trials, North Carolina offers a wide range of clinical research opportunities. Leading medical centers in Charlotte, Raleigh, and Durham are seeking participants, providing access to innovative treatments and comprehensive care.
Filter
1
Filter results
Results: 2,450
AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme
for
Glioblastoma Multiforme
Location: Durham NC, Detroit MI, Chicago IL, Dallas TX,
Sponsor: Novacea
Sex: All
Age: 18+
Code: NCT00394628
Phase1, Phase2, Recruiting
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Location: Raleigh NC, Miami FL, Salem VA, Boardman OH,
Sponsor: Tides Medical
Sex: All
Age: 18+
Code: NCT06681428
Recruiting
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
for
Multiple Myeloma
Location: Providence RI, Farmington CT, New Haven CT, Lebanon NH,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT05552222
Phase3, Recruiting
Dose-Escalation and Expansion Trial of NC-6300 in Patients With Advanced Solid Tumors or Soft Tissue Sarcoma
Relationship Between Data Obtained With the LuGENE® Multiparameter Transcriptomics Blood Test and Clinical and Standard Laboratory Features of Patients With SLE (ReLATE)
for
Lupus Erythematosus, Systemic
Location: Manhasset NY, Charlotte NC, Los Angeles CA
Sponsor: Ampel BioSolutions, LLC
Sex: All
Age: 18+
Code: NCT05845593
Recruiting
WAKIX® (Pitolisant) Pregnancy Registry
for
Pregnancy Related, Narcolepsy
Location: Morrisville NC
Sponsor: Harmony Biosciences Management, Inc.
Sex: Female
Age: 0+
Code: NCT05536011
Recruiting
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia
Location: Halifax, Portland ME, Scarborough ME, South Portland ME,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 59
Code: NCT05554393
Phase2, Recruiting
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
for
Colorectal Neoplasms
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All
Age: 18+
Code: NCT05253651
Phase3, Recruiting
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
for
Non-Small Cell Lung Cancer
Location: St. John's, Rimouski, Boston MA, Levis, Stony Brook NY,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06357533
Phase3, Recruiting
Supervised Exercise as a Therapeutic Strategy for Interstitial Cystitis/Bladder Pain Syndrome